The Discounted Cash Flow (DCF) valuation of Theravance Biopharma Inc (TBPH) is (40.50) USD. With the latest stock price at 10.25 USD, the upside of Theravance Biopharma Inc based on DCF is -495.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 7.5% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (100.57) - (25.55) | (40.50) |
| Upside | -1081.2% - -349.3% | -495.1% |